APIs and Excipients

Selecting Excipients for Controlled Release

July 02, 2018

With the right excipients, formulators can control when, where, and how an API is released.

Minakem Opens New High Containment Facility

June 25, 2018

Minakem’s facility in Belgium enhances capacity to scale production of highly potent ingredients for small to full GMP batches.

CellGenix Completes First Step of Facility Expansion for Cell-Culture Reagents

June 22, 2018

The company has completed the first phase of expansion at its headquarters in Freiburg, Germany, in anticipation of increasing demand as cell and gene therapies approach commercialization.

Sanofi Pasteur, Translate Bio in $805-Million Deal to Develop mRNA-Based Vaccines

June 22, 2018

The three-year collaboration will focus on developing vaccines for up to five infectious disease pathogens.

Canada OKs Samsung BioLogics’ mAb Drug Substance Plant

June 21, 2018

The contract development and manufacturing company has received an additional approval from Health Canada to manufacture monoclonal antibody drug substance at its first plant in Icheon, South Korea.

Cambrex Adds R&D Lab for Generic APIs

June 13, 2018

Pharmaceutical Technology's In the Lab eNewsletter

Cambrex expands its generic API research and development capabilities at its Milan, Italy site.